We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Adjustable Clot Retriever Reduces Vessel Tension During Ischemic Stroke Treatment

By HospiMedica International staff writers
Posted on 28 Jul 2022
Print article
Image: TIGERTRIEVER 13 is designed to reduce vessel tension during ischemic stroke treatment (Photo courtesy of Rapid Medical)
Image: TIGERTRIEVER 13 is designed to reduce vessel tension during ischemic stroke treatment (Photo courtesy of Rapid Medical)

Existing stent retrievers designed for neurovascular diseases such as ischemic and hemorrhagic stroke lack any adjustability ­ they open passively and are pulled from the brain fully expanded. Now, an adjustable clot retriever designed to remove thrombus from delicate brain blood vessels during an ischemic stroke can provide new safety levels for higher-risk thrombectomies.

Rapid Medical’s (Yokneam, Israel) TIGERTRIEVER 13 is the smallest revascularization device in the world to date and is designed to remove thrombus from delicate brain blood vessels during an ischemic stroke. It is the only device that adjusts to the vasculature and clot, a more atraumatic approach than existing devices. The unique adjustability of the TIGERTRIEVER portfolio comes from complex three-dimensional braiding borrowed from recent advances in aerospace engineering.

TIGERTRIEVER is precisely controlled to capture the thrombus and remove the tension from the vasculature before removal. Adjustability also gives TIGERTRIEVER 13 the lowest profile of any stent retriever - 24% smaller than 3 mm devices, providing easier navigation in challenging anatomies. The ability to tailor each procedure can provide new safety levels for higher-risk thrombectomies. Rapid Medical has received FDA 510(k) clearance for TIGERTRIEVER 13 for large vessel occlusions.

“Thousands of procedures have already been performed with TIGERTRIEVER 13 worldwide,” said James Romero, President, Americas, of Rapid Medical. “Now U.S. physicians finally have access to TIGERTRIEVER 13’s unique capabilities to further benefit patients suffering from ischemic stroke.”

“The neurovascular field has been waiting for a thrombectomy device dedicated to small vessels,” stated Dr. David Fiorella of Stony Brook University Medical Center. “Medical therapy is currently suboptimal for these patients, so there can be a huge benefit for devices that emergently restore blood flow while minimizing the potential for harm.”

Related Links:
Rapid Medical

Gold Supplier
Creatinine Meter
StatSensor Xpress Creatinine Meter
New
Wound Dressing
Thin Absorbent Wound Dressing Featuring TASA
New
Clinical Tympanic Thermometer
ri-thermo N
New
Multi-Parameter Patient Monitor
S80

Print article
FIME - Informa

Channels

AI

view channel
Image: The AI tool can also tackle dangerous inequalities in heart attack diagnosis (Photo courtesy of Freepik)

AI Algorithm Integrates Cardiac Troponin Test Results with Clinical Data to Quickly Rule out Heart Attacks in Patients

The accepted standard for diagnosing myocardial infarction, or heart attack, involves assessing the blood for troponin levels. However, this approach applies the same benchmark for all patients, failing... Read more

Critical Care

view channel
Image: New technology gives patients the power to heal chronic wounds using their own blood (Photo courtesy of RedDress)

POC Solution Creates In Vitro Blood Clots from Patient’s Own Whole Blood in Real-Time to Treat Post-Surgical Wounds

Blood clots are a natural mechanism of the body's healing process. However, for chronic wounds resulting from diabetes and other conditions, blood is unable to reach these areas, hampering the initiation... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: IntelliSep is the first FDA-cleared diagnostic tool to assess cellular host response to aid in identifying ED patients with sepsis (Photo courtesy of Cytovale)

Rapid Microfluidic Test Demonstrates Efficacy as Diagnostic Aid to Improve Sepsis Triage in ED

Sepsis is the primary cause of mortality worldwide, accounting for over 350,000 fatalities annually in the United States alone, a figure that surpasses deaths from opioid overdoses, prostate cancer, and... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.